Selected research
Industry Research
Multi-Omics Service Industry Research Report 2026
Market perspective
The global Multi-Omics Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Multi-Omics Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Multi-Omics Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Multi-Omics Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Multi-Omics Service include Metware, Genechem, Aptbiotech, Illumina, BGI, Singleronbio, Majorbio Group, Bioprofile and Dalton Bioanalytics, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Multi-Omics Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Multi-Omics Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Multi-Omics Service Market by Company
Metware
Genechem
Aptbiotech
Illumina
BGI
Singleronbio
Majorbio Group
Bioprofile
Dalton Bioanalytics
Source BioScience
Psomagen
Biogenity
Sapient
Creative Biolabs
X-omics
RayBiotech
Sampled
Multi-Omics Service Segment by Type
Single-Cell Multi-omics
Spatial Multi-omics
Others
Multi-Omics Service Segment by Application
Cancer Research
Rare Disease Diagnostics
Drug Development
Crop Breeding
Microbiome Research
Others
Multi-Omics Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Multi-Omics Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Multi-Omics Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Multi-Omics Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Multi-Omics Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Single-Cell Multi-omics
- Spatial Multi-omics
- Others
Applications
- Cancer Research
- Rare Disease Diagnostics
- Drug Development
- Crop Breeding
- Microbiome Research
- Others
Companies covered
- Metware
- Genechem
- Aptbiotech
- Illumina
- BGI
- Singleronbio
- Majorbio Group
- Bioprofile
- Dalton Bioanalytics
- Source BioScience
- Psomagen
- Biogenity
- Sapient
- Creative Biolabs
- X-omics
- RayBiotech
- Sampled
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Multi-Omics Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Single-Cell Multi-omics
- 2.2.3 Spatial Multi-omics
- 2.2.4 Others
- 2.3 Multi-Omics Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Cancer Research
- 2.3.3 Rare Disease Diagnostics
- 2.3.4 Drug Development
- 2.3.5 Crop Breeding
- 2.3.6 Microbiome Research
- 2.3.7 Others
- 2.4 Assumptions and Limitations
3 Multi-Omics Service Breakdown Data by Type
- 3.1 Global Multi-Omics Service Historic Market Size by Type (2021-2026)
- 3.2 Global Multi-Omics Service Forecasted Market Size by Type (2027-2032)
4 Multi-Omics Service Breakdown Data by Application
- 4.1 Global Multi-Omics Service Historic Market Size by Application (2021-2026)
- 4.2 Global Multi-Omics Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Multi-Omics Service Market Perspective (2021-2032)
- 5.2 Global Multi-Omics Service Growth Trends by Region
- 5.2.1 Global Multi-Omics Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Multi-Omics Service Historic Market Size by Region (2021-2026)
- 5.2.3 Multi-Omics Service Forecasted Market Size by Region (2027-2032)
- 5.3 Multi-Omics Service Market Dynamics
- 5.3.1 Multi-Omics Service Industry Trends
- 5.3.2 Multi-Omics Service Market Drivers
- 5.3.3 Multi-Omics Service Market Challenges
- 5.3.4 Multi-Omics Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Multi-Omics Service Players by Revenue
- 6.1.1 Global Top Multi-Omics Service Players by Revenue (2021-2026)
- 6.1.2 Global Multi-Omics Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Multi-Omics Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Multi-Omics Service Head Office and Area Served
- 6.4 Global Multi-Omics Service Players, Product Type & Application
- 6.5 Global Multi-Omics Service Manufacturers Established Date
- 6.6 Global Multi-Omics Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Multi-Omics Service Market Size (2021-2032)
- 7.2 North America Multi-Omics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Multi-Omics Service Market Size by Country (2021-2026)
- 7.4 North America Multi-Omics Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Multi-Omics Service Market Size (2021-2032)
- 8.2 Europe Multi-Omics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Multi-Omics Service Market Size by Country (2021-2026)
- 8.4 Europe Multi-Omics Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Multi-Omics Service Market Size (2021-2032)
- 9.2 Asia-Pacific Multi-Omics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Multi-Omics Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Multi-Omics Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Multi-Omics Service Market Size (2021-2032)
- 10.2 South America Multi-Omics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Multi-Omics Service Market Size by Country (2021-2026)
- 10.4 South America Multi-Omics Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Multi-Omics Service Market Size (2021-2032)
- 11.2 Middle East & Africa Multi-Omics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Multi-Omics Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Multi-Omics Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Metware
- 12.1.1 Metware Company Information
- 12.1.2 Metware Business Overview
- 12.1.3 Metware Revenue in Multi-Omics Service Business (2021-2026)
- 12.1.4 Metware Multi-Omics Service Product Portfolio
- 12.1.5 Metware Recent Developments
- 12.2 Genechem
- 12.2.1 Genechem Company Information
- 12.2.2 Genechem Business Overview
- 12.2.3 Genechem Revenue in Multi-Omics Service Business (2021-2026)
- 12.2.4 Genechem Multi-Omics Service Product Portfolio
- 12.2.5 Genechem Recent Developments
- 12.3 Aptbiotech
- 12.3.1 Aptbiotech Company Information
- 12.3.2 Aptbiotech Business Overview
- 12.3.3 Aptbiotech Revenue in Multi-Omics Service Business (2021-2026)
- 12.3.4 Aptbiotech Multi-Omics Service Product Portfolio
- 12.3.5 Aptbiotech Recent Developments
- 12.4 Illumina
- 12.4.1 Illumina Company Information
- 12.4.2 Illumina Business Overview
- 12.4.3 Illumina Revenue in Multi-Omics Service Business (2021-2026)
- 12.4.4 Illumina Multi-Omics Service Product Portfolio
- 12.4.5 Illumina Recent Developments
- 12.5 BGI
- 12.5.1 BGI Company Information
- 12.5.2 BGI Business Overview
- 12.5.3 BGI Revenue in Multi-Omics Service Business (2021-2026)
- 12.5.4 BGI Multi-Omics Service Product Portfolio
- 12.5.5 BGI Recent Developments
- 12.6 Singleronbio
- 12.6.1 Singleronbio Company Information
- 12.6.2 Singleronbio Business Overview
- 12.6.3 Singleronbio Revenue in Multi-Omics Service Business (2021-2026)
- 12.6.4 Singleronbio Multi-Omics Service Product Portfolio
- 12.6.5 Singleronbio Recent Developments
- 12.7 Majorbio Group
- 12.7.1 Majorbio Group Company Information
- 12.7.2 Majorbio Group Business Overview
- 12.7.3 Majorbio Group Revenue in Multi-Omics Service Business (2021-2026)
- 12.7.4 Majorbio Group Multi-Omics Service Product Portfolio
- 12.7.5 Majorbio Group Recent Developments
- 12.8 Bioprofile
- 12.8.1 Bioprofile Company Information
- 12.8.2 Bioprofile Business Overview
- 12.8.3 Bioprofile Revenue in Multi-Omics Service Business (2021-2026)
- 12.8.4 Bioprofile Multi-Omics Service Product Portfolio
- 12.8.5 Bioprofile Recent Developments
- 12.9 Dalton Bioanalytics
- 12.9.1 Dalton Bioanalytics Company Information
- 12.9.2 Dalton Bioanalytics Business Overview
- 12.9.3 Dalton Bioanalytics Revenue in Multi-Omics Service Business (2021-2026)
- 12.9.4 Dalton Bioanalytics Multi-Omics Service Product Portfolio
- 12.9.5 Dalton Bioanalytics Recent Developments
- 12.10 Source BioScience
- 12.10.1 Source BioScience Company Information
- 12.10.2 Source BioScience Business Overview
- 12.10.3 Source BioScience Revenue in Multi-Omics Service Business (2021-2026)
- 12.10.4 Source BioScience Multi-Omics Service Product Portfolio
- 12.10.5 Source BioScience Recent Developments
- 12.11 Psomagen
- 12.11.1 Psomagen Company Information
- 12.11.2 Psomagen Business Overview
- 12.11.3 Psomagen Revenue in Multi-Omics Service Business (2021-2026)
- 12.11.4 Psomagen Multi-Omics Service Product Portfolio
- 12.11.5 Psomagen Recent Developments
- 12.12 Biogenity
- 12.12.1 Biogenity Company Information
- 12.12.2 Biogenity Business Overview
- 12.12.3 Biogenity Revenue in Multi-Omics Service Business (2021-2026)
- 12.12.4 Biogenity Multi-Omics Service Product Portfolio
- 12.12.5 Biogenity Recent Developments
- 12.13 Sapient
- 12.13.1 Sapient Company Information
- 12.13.2 Sapient Business Overview
- 12.13.3 Sapient Revenue in Multi-Omics Service Business (2021-2026)
- 12.13.4 Sapient Multi-Omics Service Product Portfolio
- 12.13.5 Sapient Recent Developments
- 12.14 Creative Biolabs
- 12.14.1 Creative Biolabs Company Information
- 12.14.2 Creative Biolabs Business Overview
- 12.14.3 Creative Biolabs Revenue in Multi-Omics Service Business (2021-2026)
- 12.14.4 Creative Biolabs Multi-Omics Service Product Portfolio
- 12.14.5 Creative Biolabs Recent Developments
- 12.15 X-omics
- 12.15.1 X-omics Company Information
- 12.15.2 X-omics Business Overview
- 12.15.3 X-omics Revenue in Multi-Omics Service Business (2021-2026)
- 12.15.4 X-omics Multi-Omics Service Product Portfolio
- 12.15.5 X-omics Recent Developments
- 12.16 RayBiotech
- 12.16.1 RayBiotech Company Information
- 12.16.2 RayBiotech Business Overview
- 12.16.3 RayBiotech Revenue in Multi-Omics Service Business (2021-2026)
- 12.16.4 RayBiotech Multi-Omics Service Product Portfolio
- 12.16.5 RayBiotech Recent Developments
- 12.17 Sampled
- 12.17.1 Sampled Company Information
- 12.17.2 Sampled Business Overview
- 12.17.3 Sampled Revenue in Multi-Omics Service Business (2021-2026)
- 12.17.4 Sampled Multi-Omics Service Product Portfolio
- 12.17.5 Sampled Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst